Page 6 - Mark Diagnostics News Today

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Extended Stay America, Inc....

(1) Vancouver, British Columbia--(Newsfile Corp. - March 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its sponsored research collaboration with The Metabolomics Innovation Centre (TMIC) was successful in receiving funding from the Novel Technology Application in Cancer Prevention and Early Detection Spark Grants competition. This comes after the organizers of the competition, the Canadian Cancer Society/Canadian Inst...

U.S. stock futures were mixed Monday as the 10-year Treasury yield held near 1-year highs.

TOP NEWS SUMMARY: AstraZeneca and Oxford insist Covid-19 jab is safe Mon, 15th Mar 2021 11:00 (Alliance News) - The following is a summary of top news stories Monday. COMPANIES The director of the Oxford Vaccine Group said there was no link between the jab it developed with Anglo-Swedish pharmaceutical giant AstraZeneca and blood clotting, after several countries suspended its use. Andrew Pollard said there was "very reassuring evidence that there is no increase in a blood clot phenomenon here ...

BioMark Diagnostics, Inc.: BioMark Grants Options Vancouver, British Columbia--(Newsfile Corp. - March 2, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that it has granted 2,100,000 incentive stock options under the Companys Stock Option Plan ("Option Plan") to third-party consultants to support market communication and corporate strategy as it advances its commercialization efforts. Each option is exercisable into one common share a...

CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Thursday reported a loss of...

Concert Pharmaceuticals Inc (NASDAQ: CNCE) (before the market open) Kala Pharmaceuticals Inc (NASDAQ: KALA) (before the market open) Jounce Therapeutics Inc (NASDAQ: JNCE) (before the market open) Intellia Therapeutics Inc (NASDAQ: NTLA) (before the market open) Moderna Inc (NASDAQ: MRNA) (before the market open) Radius Health Inc (NASDAQ: RDUS) (before the market open) Insmed Incorporated (NASDAQ: INSM) (before the market open) Intercept Pharmaceuticals Inc (NASDAQ: ICPT) (before the market op...

Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the publication of a manuscript in Frontiers in Cellular and Infection Microbiology t...

(1) Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. has entered into a collaborative research and development agreement with Phytronix Technologies Inc. ("Phytronix") to advance the development of BioMarks early lung cancer screening applications using Phytronix-proprietary Laser Diode Thermal Desorption (LDTD)...

Gainers Ayala Pharmaceuticals (NASDAQ:AYLA) shares rose 61.99% to $21.06 during Thursday's regular session. The current volume of 576.7K shares is ...